Patents by Inventor Hartmut Ney

Hartmut Ney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080102133
    Abstract: The invention relates to novel dosage forms for proton pump antagonists.
    Type: Application
    Filed: September 30, 2005
    Publication date: May 1, 2008
    Inventors: Antje Brueck-Scheffler, Isabel Anstett-Klein, Simone Hiltl, Hartmut Ney
  • Publication number: 20080050428
    Abstract: The invention relates to novel extended release dosage forms for reversible proton pump antagonists comprising a basic excipient.
    Type: Application
    Filed: September 30, 2005
    Publication date: February 28, 2008
    Applicant: Altana Pharma AG
    Inventors: Hartmut Ney, Isabel Anstett-Klein, Simone Hiltl, Antje Brueck-Scheffler
  • Publication number: 20070122474
    Abstract: The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation, an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohols, triglycerides, partial triglycerides and fatty acid esters.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 31, 2007
    Inventors: Rango Dietrich, Rudolf Linder, Hartmut Ney
  • Patent number: 7175854
    Abstract: The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohol, triglyceride, partial glyceride and fatty acid ester.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: February 13, 2007
    Assignee: Altana Pharma AG
    Inventors: Rango Dietrich, Rudolf Linder, Hartmut Ney
  • Patent number: 7147869
    Abstract: A rapidly disintegrating tablet for oral administration of acid-labile active ingredients is described. The rapidly disintegrating tablet for oral administration of an acid-labile active ingredient comprises a plurality of individual active ingredient units together with pharmaceutical excipients, where the acid-labile active ingredient is present in the individual active ingredient units in a matrix composed of a mixture comprising at least one solid paraffin and one or more substances from the group of fatty alcohol, triglyceride and fatty acid ester, and where excipients which, on oral intake of the tablet, bring about rapid disintegration of the tablet are present.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: December 12, 2006
    Assignee: Altana Pharma AG
    Inventors: Rango Dietrich, Hartmut Ney, Rudolf Linder
  • Publication number: 20060269600
    Abstract: Dosage forms for oral administration of a PDE4 inhibitor whose solubility is slight are described. They contain PVP as a binder.
    Type: Application
    Filed: August 10, 2006
    Publication date: November 30, 2006
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • Publication number: 20060263426
    Abstract: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
    Type: Application
    Filed: March 17, 2006
    Publication date: November 23, 2006
    Inventors: Rango Dietrich, Hartmut Ney
  • Publication number: 20060216346
    Abstract: Dosage forms for the oral administration of the magnesium salt of (S)-pantoprazole are described.
    Type: Application
    Filed: May 7, 2004
    Publication date: September 28, 2006
    Applicant: Altana Pharma
    Inventors: Rango Dietrich, Isabel Anstett-Klein, Marc Schiller, Hartmut Ney, Manfred Hartmann, Sabine Schafer-Preuss
  • Publication number: 20060204568
    Abstract: The invention relates to novel dosage forms for proton pump antagonists.
    Type: Application
    Filed: April 8, 2004
    Publication date: September 14, 2006
    Inventors: Rango Dietrich, Bernd-Michael Haas, Hartmut Ney, Simone Hiltl
  • Patent number: 7041313
    Abstract: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
    Type: Grant
    Filed: August 7, 1999
    Date of Patent: May 9, 2006
    Assignee: Altana Pharma AG
    Inventors: Rango Dietrich, Hartmut Ney
  • Publication number: 20050159492
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: February 19, 2003
    Publication date: July 21, 2005
    Applicant: Altana Pharma AG
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • Publication number: 20040110661
    Abstract: A rapidly disintegrating tablet for oral administration of acid-labile active ingredients is described. The rapidly disintegrating tablet for oral administration of an acid-labile active ingredient comprises a plurality of individual active ingredient units together with pharmaceutical excipients, where the acid-labile active ingredient is present in the individual active ingredient units in a matrix composed of a mixture comprising at least one solid paraffin and one or more substances from the group of fatty alcohol, triglyceride and fatty acid ester, and where excipients which, on oral intake of the tablet, bring about rapid disintegration of the tablet are present.
    Type: Application
    Filed: June 3, 2003
    Publication date: June 10, 2004
    Inventors: Rango Dietrich, Hartmut Ney, Rudolf Linder
  • Publication number: 20040058896
    Abstract: The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohol, triglyceride, partial glyceride and fatty acid ester.
    Type: Application
    Filed: September 11, 2003
    Publication date: March 25, 2004
    Inventors: Rango Dietrich, Rudolf Linder, Hartmut Ney
  • Patent number: 5997903
    Abstract: The invention relates to oral presentation forms for pantoprazole, which consist of a core, an intermediate layer and an outer layer which is resistant to gastric juice.
    Type: Grant
    Filed: December 17, 1993
    Date of Patent: December 7, 1999
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventors: Rango Dietrich, Hartmut Ney